Alterity raises $35M in placement to institutional investors
Filed with ASX · · 4 pages · English
Alterity Therapeutics Ltd. on 6ix
Story so far
Earlier from Alterity Therapeutics
- Company update on Annual Report 2020
- Preliminary Final Report
- New data independently confirms safety profile of ATH434
- Pause in Trading
- Meeting with US FDA provides development path for ATH434
Later from Alterity Therapeutics
- Alterity completes Placement Tranche 1 raising $10M
- MSA patients enrolled in bioMUSE Study
- US patent for next generation neurodegenerative diseases
- Chairmans Address 2020 Annual General Meeting
- Prospectus filed pursuant to SEC Rule 424(b)(3)
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics